Changes in serum BDNF levels after treatment of panic disorder patients

Aim: Panic disorder is a significant psychiatric disorder that more frequently occurs in women, with daily attacks such as fear ofdeath, limiting the patient’s daily life. It is often associated with agoraphobia. The aim of this study was to investigate the relationshipbetween BDNF levels and the clinical features of panic disorder.Material and Methods: The study was carried out between January 2015 and July 2015 with 42 female patients and 38 healthy femaleswho were admitted to Psychiatry Outpatient Clinic. The patients who were diagnosed with panic disorder without agoraphobiaincluded in the study. The Panic Disorder Severity Scale (PDSS) was applied to the patients. Serum BDNF was measured by sandwichELISA.Results: The mean age of the 38 female patients was 35.1 ± 11.5 years. The mean age of the control group of 38 healthy womenwas 34.9 ± 9.82 years. Serum BDNF levels measured before treatment were significantly lower than BDNF levels measured aftertreatment (p< 0.001). Serum BDNF levels measured before treatment were significantly lower than BDNF levels of the control group(p

PDF

___

1. Pine DS, Mc Clure EB. Anksiyete bozuklukları: Klinik özellikleri. In: Aydın H, Bozkurt A, Editors. Kaplan & Sadock’s Comprehensive Text- book of Psychiatry. 8th Edition. Ankara: Güneş Kitabevi; 2007. p. 1768-71.
2. Grillon C. Anxiety Disorders. Psychophysiological Aspects. In: Sadock BJ, Sadock VA, Editors. Kaplan & Sadock’s Comprehensive Textbook of Psychiatry. 8th Edition. Philadelphia: Lippincott Williams & Wilkins; 2005. p. 1728- 39.
3. Bayraktar E. Panik bozukluğu ve agorafobi. Güncel Klinik Psikiyatri 2008;209-22.
4. Hashimoto K, Shimizu E, Iyo M. Critical role of brain-derived neurotrophic factor in mood disorders. Brain Res. Rev 2004;45:104-14.
5. Javanmard M, Shlik J, Kennedy SH, et al. Neuroanatomic correlates of CCK-4-induced panic attacks in healthy humans: a comparison of two time points. Biol. Psychiatry 1999;45:872-82.
6. Zedkova L, Coupland NJ, Man GC, et al. Panic-related responses to pentagastrin, flumazenil, and thyrotropinreleasing hormone in healthy volunteers. Depress. Anxiety 2003;17:78-87.
7. Nutt DJ. Altered central α 2 adrenoceptor sensitivity in panic disorder. Arch Gen Psychiatry 1989;46:165-9.
8. Papp LA, Klein DF, Martinez J. Diagnostic and substance specificity of carbon dioxide induced panic. Am J Psychiatry 1993;150:250-7.
9. Slaap BR, van Vliet IM, Westenberg HG, et al. MHPG and heart rate as correlates of nonresponse to drug therapy in panic disorder patients. A preliminary report. Psychopharmacology (Berl.) 1996;127:353-8.
10. Kobayashi K, Shimizu E, Hashimoto K, et al. Serum brainderived neurotrophic factor (BDNF) levels in patients with panic disorder: as a biological predictor of response to group behavioral therapy. Progr. Neu- ropsychopharmacol. Biol. Psychiatry 2005;29:658-63.
11. Lee IS, Kim KJ, Kang EH, et al. β-adrenoceptor affinity as a biological predictor of treatment response to paroxetine in patients with acute panic disorder. Journal of affective disorders 2008;10:156-60.
12. Gul IG, Cumurcu BE, Karlidag R, et al. Ghrelin and lipid levels in panic disorder before and after treatment and their relationship with agoraphobia. Psychiatria Danubina 2015;27:250-8.
13. Lam P, Cheng CY, Hong CJ, et al. Association study of a brain-derived neurotrophic factor (Val66Met) genetic polymorphism and panic disorder. Neuropsychobiology 2004;49:178-81.
14. Frustaci A, Pozzi G, Gianfagna F, et al. Meta-analysis of the brain-derived neurotrophic factor gene (BDNF) Val66Met polymorphism in anxiety disorders and anxiety-related personality traits. Neuropsychobiology 2008;58:163-70.
15. Shimizu E, Hashimoto K, Koizumi H, et al. No association of the brain-derived neurotrophic factor (BDNF) gene polymorphisms with panic disorder. Progress in Neuro- Psychopharmacology and Biological Psychiatry 2005;29:708-12.
16. Zou Z, Qiu J, Huang Y, et al. The BDNF Val66Met gene polymorphism is associated with increased alexithymic and anticipatory anxiety in patients with panic disorder. Psychology Health Med 2019;24:505-11.
17. Karege F, Schwald M, Cisse M. Postnatal developmental profile of brain-derived neurotrophic factor in rat brain and platelets. Neurosci Lett 2002;328:261-4.
18. Lindsay RM, Wiegand SJ, Altar CA, et al. Neuro- trophic factors: from molecule to man. Trends Neurosci 1994;17:182-90.
19. Martinowich K, Husseini M, Bai L. New insights into BDNF function in depression and anxiety. Nat neurosci 2007;10:1089-93.
20. Shimizu E, Hashimoto K, Okamura N, et al. Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants. Biol. Psychiatry 2003;54:70-5.
21. Ribasés M, Gratacos M, Fernandez Aranda F, et al. Association of BDNF with anorexia, bulimia and age of onset of weight loss in six European populations. Human Molecular Genetics 2004;13:1205-12.
22. Sohrabji F, Lewis DK. Estrogen-BDNF interactions: implications for neurodegenerative diseases. Front Neuroendocrinol 2006;27:404-14.
23. Scharfman HE, MacLusky NJ. Estrogen and brain-derived neurotrophic factor (BDNF) in hippocampus: complexity of steroid hormone-growth factor interactions in the adult CNS. Front Neuroendocrinol 2006;27:415-35.
24. MacQueen G, Chokka P. Special issues in the management of depression in women. Can J Psychiatry 2004;49:27S-40S.
25. Statistical manual of mental disorders. American Psychiatric Association. Washington, DC, 1994;886.
26. Shear MK, Brown TA, Barlow DH, et al. Multicenter collaborative panic disorder severity scale. Am J Psychiatry 1997;154:1571-5.
27. Houck PR, Spiegel DA, Shear MK, et al. Reliability of the selfreport version of the panic disorder severity scale. Depress. Anxiety 2002;15:183-5.
28. Monkul ES, Tural Ü, Onur E, et al. Panic Disorder Severity Scale: reliability and validity of the Turkish version. Depression Anxiety 2004;20:8-16.
29. Zhang H, Ozbay F, Lappalainen J, et al. Brain derived neurotrophic factor (BDNF) gene variants and Alzheimer’s disease, affective disorders, posttraumatic stress disorder, schizophrenia, and substance dependence. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 2006;141:387-93.
30. Chen K, Wang N, Zhang J, et al. Is the V al66 M et polymorphism of the brain-derived neurotrophic factor gene associated with panic disorder? A meta-analysis. Asia- Pacific Psychiatry 2017;9:e12228.
31. Ströhle A, Stoy M, Graetz B, et al. Acute exercise ameliorates reduced brain-derived neurotrophic factor in patients with panic disorder. Psychoneuroendocrinology 2010;35364-8.
32. Molendijk ML, Bus BA, Spinhoven P, et al. Gender specific associations of serum levels of brain-derived neurotrophic factor in anxiety. The World Journal of Biological Psychiatry 2012;13:535-43.